Everolimus in combination with octreotide LAR in thymic atypical carcinoid

Thymic atypical carcinoids are extremely rare tumors and have a poor prognosis owing to their aggressive clinical course. The efficacy of treatments other than complete surgical resection is unclear. We herein report a postoperative recurrent case of thymic atypical carcinoid treated with everolimus...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakane, Tadashi, Nakano, Tomoharu, Hagui, Emi, Haneda, Hiroshi, Okuda, Katsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212656/
https://www.ncbi.nlm.nih.gov/pubmed/37037489
http://dx.doi.org/10.1111/1759-7714.14887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212656/
https://www.ncbi.nlm.nih.gov/pubmed/37037489
http://dx.doi.org/10.1111/1759-7714.14887

Ejemplares similares